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Toll-like receptors (TLRs) recognize specifi  c 
microbial pathogen–associated molecular pat-
terns and constitute a major mechanism to 
  respond to microbial infection. Engagement of 
TLRs activates the production of proinfl  am-
matory cytokines, such as IL-12 and TNFα, 
and up-regulates co-stimulatory molecules on 
APCs. TLR-induced responses are important 
not only for innate immunity but also for 
  generation of proper adaptive immunity against 
microbial infection (1, 2). TLR signals are 
mainly transduced through two pathways, the 
myeloid diff   erentiation primary response pro-
tein 88 (MyD88)–dependent and the Toll/Il-1 
receptor domain–containing adaptor–inducing 
interferon-β–dependent pathways. The MyD88 
pathway activates IκB kinase α/β/γ, resulting 
in IκB degradation and nuclear translocation of 
NF-κB to activate transcription of proinfl  am-
matory cytokines (3–5). In addition, MyD88 is 
required for activation of the c-Jun N-terminal 
kinase and p38 mitogen-associated protein 
  kinases (MAPKs) that are also important for 
TLR-induced infl   ammatory responses (6–9). 
The Toll/Il-1 receptor domain–containing 
adaptor–inducing interferon-β–dependent path-
way, which is activated by TLR3 and TLR4, 
leads to phosphorylation and activation of IFN 
regulatory factor 3 (IRF3) and late-phase NF-κB 
activation (10–14).
Interestingly, both diacylglycerol (DAG) 
and phosphatidic acid (PA) are induced after 
stimulation of macrophages (Mϕ) with lipo-
polysaccharide (LPS) and lipopeptide, ligands 
for TLR4 and TLR2, respectively. Inhibition of 
DAG and PA production by chemicals reduces 
TNFα and nitric oxide production in Mϕ 
treated with LPS or lipopeptide, suggesting that 
these second messengers may participate in TLR 
signal transduction (15–17). However, there is no 
reported genetic evidence that the modulation 
of DAG and/or PA concentrations may aff  ect 
TLR signaling and innate immunity.
TLR-mediated responses are critical for 
host defense against microbial organisms such 
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patterns and are critical for innate immunity against microbial infection. Diacylglycerol 
(DAG) kinases (DGKs) regulate the intracellular levels of two important second messengers 
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(PA). We demonstrate that the 𝗇 isoform of the DGK family (DGK𝗇) is expressed in macro-
phages (M𝗟) and dendritic cells. DGK𝗇 defi  ciency results in impaired interleukin (IL) 12 and 
tumor necrosis factor 𝗂 production following TLR stimulation in vitro and in vivo, increased 
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Akt pathway and that inhibition of PI3K activity or treatment with PA can restore lipopoly-
saccharide-induced IL-12 production by DGK𝗇-defi  cient M𝗟. Collectively, our data provide 
the fi  rst genetic evidence that an enzyme involved in DAG/PA metabolism plays an impor-
tant role in innate immunity and indicate that DGK𝗇 promotes TLR responses via a pathway 
involving inhibition of PI3K.
CORRESPONDENCE
Xiao-Ping Zhong: 
zhong001@mc.duke.edu
Abbreviations used: BMMϕ, 
bone marrow–derived Mϕ; 
DAG, diacylglycerol; DGK, 
DAG kinase; H&E, hematoxylin 
and eosin; LCMV, lymphocytic 
choriomeningitis virus; 
MAPK, mitogen-associated 
protein kinase; Mϕ, 
macrophage(s); MyD88, 
  myeloid diff  erentiation primary 
response protein 88; PA, phos-
phatidic acid; PI3K, phos-
phatidylinositol 3–kinase; PIP3, 
phosphatidylinositol (3,4,5)-
trisphosphate; PKC, protein 
kinase C; RasGRP, Ras guanyl 
nucleotide-releasing protein; 
SHP-1, Src homology 2 
  domain–containing phosphatase 1; 
STAg, T. gondii–soluble 
  tachyzoite Ag; TLR, Toll-like 
receptor.
C.-H. Liu, F.S. Machado, and R. Guo contributed equally to 
this work.782  DGKζ IN TLR RESPONSES AND TOXOPLASMOSIS | Liu et al.
as Toxoplasma gondii. T. gondii is an intracellular opportunistic 
protozoan that causes widespread infection in humans and 
animals. It can establish life-long chronic infection in 
  immune-competent hosts but causes serious health problems 
in immuno  compromised individuals, such as HIV patients 
(18–20).  T. gondii is recognized by several TLRs (such as 
TLR2 and TLR11) and the CC chemokine receptor 5 (9, 
21–26). TLR signaling and the subsequent production of 
IL-12 by DCs, Mϕ, and neutrophils induce Th1 adaptive 
immune responses and IFN-γ production (27), which is critical 
for resistance to T. gondii infection (28–30). In mouse models, 
defi   ciency of MyD88 expression results in lethality after 
T. gondii infection (22) and impairment of host defense 
against other microbes caused by the inhibition of both innate 
and adaptive immunity (11, 31, 32). Mechanisms that regulate 
TLR signaling during innate immune responses to T. gondii 
are not well understood.
Given their abilities to induce potent proinfl  ammatory 
responses, TLR signals must be tightly controlled. The class 
IA family of PI3Ks, which promote cell survival and regu-
late transcription and other cellular processes, negatively 
regulate TLR2-, TLR4-, and TLR9-induced IL-12 pro-
duction in DCs (33–35). Although multiple mechanisms 
may mediate the inhibitory eff  ects of PI3K on TLR re-
sponses, recent evidence indicates that PI3K may do so 
through Akt-mediated phosphorylation and inactivation of 
glycogen synthase kinase–3β (35, 36). Glycogen synthase 
kinase–3β is critical for infl  ammatory responses induced 
by several TLRs (35). An important question raised is 
how PI3K activity is regulated to ensure productive TLR-
  induced responses.
DAG kinases (DGKs) are a family of enzymes that catalyze 
the conversion of DAG to PA by phosphorylation. DGKs 
may play important roles in signaling from many receptors 
and modulate diverse cellular processes, because their en-
zyme activity infl  uences both DAG and PA levels (37, 38). 
We have previously demonstrated that DGKζ is an impor-
tant negative regulator of T cell receptor signaling and T cell 
function in mice (39, 40). More recent experiments have 
  revealed that DGKζ negatively regulates FcεRI-induced 
cyto  kine production but positively controls mast cell degranu-
lation in vitro and in vivo (41). In this paper, we demonstrate 
that DGKζ is expressed in DCs and Mϕ and that its ex-
pression is up-regulated after LPS stimulation. DGKζ defi  -
ciency leads to impaired TNFα and IL-12 production after 
TLR stimulation both in vitro and in vivo. Mice defi  cient of 
DGKζ show decreased susceptibility to LPS-induced shock, 
fail to mount eff  ective innate and adaptive immune responses 
against T. gondii, and manifest enhanced susceptibility to 
toxoplasmosis. Mechanistically, DGKζ defi  ciency results in 
the elevation of phosphatidylinositol (3,4,5)-trisphosphate 
(PIP3) levels and Akt activation in Mϕ but does not inhibit 
IκB degradation or activation of p38 and Erk1/2 MAPKs. 
Inhibition of PI3K activity or treatment with PA can restore 
LPS-induced IL-12 production by DGKζ-defi  cient  Mϕ. 
These observations provide the fi  rst genetic evidence that an 
enzyme involved in DAG and/or PA metabolism plays an 
important role in TLR signaling and innate immunity against 
a parasitic pathogen and reveal that DGKζ is a novel negative 
regulator of the PI3K–Akt pathway.
RESULTS
Expression of DGK𝗇 in DCs and M𝗟
Two DGKζ isoforms diff  ering only at their N-termini have 
been identifi  ed. The molecular masses of the ζ1 and ζ2  isoforms 
are 115 and 130 kD, respectively (42). Using Western blotting, 
we revealed that DGKζ1 is expressed in the Mϕ cell lines 
Raw264.7 and J774. In bone marrow–derived Mϕ (BMMϕ) 
and DCs generated from WT mice, both the ζ1 and ζ2  isoforms 
were detected, with the ζ1 isoform predominantly expressed 
(Fig. 1 A). None of these DGKζ isoforms were detected in 
DGKζ-defi  cient Mϕ and DCs, confi  rming the successful tar-
geting of the DGKζ locus. Defi  ciency of DGKζ appeared not 
to globally perturb DCs and myeloid cell development, because 
Figure 1.  DC development in DGK𝗇-defi  cient mice. (A) Expression of 
DGKζ in Mϕ and DCs. DGKζ protein expression in Raw264.7 and J774 Mϕ 
cell lines, BMMϕ, and DCs from WT and DGKζ-defi  cient mice was detected 
by Western blot analysis using an anti-DGKζ antibody (reference 69). 
The blots were stripped and reprobed with an antitubulin antibody to 
determine equal protein loading. BMMϕ and DCs were differentiated from 
bone marrow progenitor cells using M-CSF– and GM-CSF–containing 
media, respectively. (B) Quantifi  cation of CD11c+ cells in WT and 
DGKζ-defi  cient spleens. BSA gradient–enriched WT and DGKζ−/− splenic 
DCs were stained for CD11c and CD8. Total CD11c+ cells were calculated 
after FACS analysis (n = 3). Data shown are the mean ± SD. (C) CD8 
staining of splenic CD11c+ cells as described in B. Numbers indicate the 
percentages of gated cell populations.JEM VOL. 204, April 16, 2007  783
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similar numbers of CD11c+CD8+ DCs (Fig. 1, B and C), as 
well as CD11b+ cells (40), were present in both WT and 
DGKζ-defi  cient mice.
Impairment of IL-12 p40 and TNF𝗂 production 
in DGK𝗇-defi  cient DCs and M𝗟 after TLR stimulation
We examined the effects of DGKζ deficiency on IL-12 
p40 and TNFα production in DCs and Mϕ. Splenic DCs 
from WT and DGKζ-defi  cient mice were isolated and left 
  unstimulated or stimulated with LPS to activate via TLR4 or 
T. gondii–soluble tachyzoite Ag (STAg), which activates via 
several pathways, including TLR2 and TLR11 (21). After 24 h 
of stimulation, IL-12 p40 (Fig. 2, A and B) and TNFα (Fig. 2, 
C and D) production by DGKζ-defi  cient DCs were consider-
ably lower than by WT DCs. Similar to DCs, DGKζ-defi  cient 
BMMϕ produced less IL-12 p40 and TNFα than WT 
BMMϕ after stimulation with LPS (Fig. 2, E and F), 
Pam3CSK4 (Fig. 2, G and H), and Poly(I:C) (Fig. 2, I and J). 
Both WT and DGKζ-defi  cient BMMϕ and DCs expressed 
similar levels of TLR4 and other molecules (Fig. 2 K), suggest-
ing that the impaired production of these proinfl  ammatory 
cytokines was not caused by decreased TLR ex  pression or 
global alteration of Mϕ properties. Because LPS, Pam3CSK4, 
and Poly(I:C) activates cells via TLR4, TLR1/2, and TLR3, 
respectively (43–45), these data indicate that DGKζ is 
  involved in signal transduction downstream of   multiple 
TLR receptors.
Decreased production of IL-12 p40 and TNF𝗂 
in DGK𝗇-defi  cient mice after in vivo TLR stimulation
In addition to DCs and Mϕ, many other cell lineages such as 
neutrophils produce proinfl   ammatory cytokines in response 
to TLR stimulation. To determine how DGKζ defi  ciency 
may aff  ect TLR-induced responses in vivo, WT and DGKζ-
defi  cient mice on a C57BL/6 genetic background were 
  injected intraperitoneally with LPS, STAg, or PBS as a control. 
6 h after injection, serum IL-12 and TNFα concentrations in 
DGKζ-defi  cient mice were lower than in WT control mice 
Figure 2.  Impairment of proinfl  ammatory cytokine produc-
tion in DGK𝗇−/− DCs and BMM𝗟. (A–D) Measurement of cytokine 
production in DCs. Splenic DCs from WT and DGKζ−/− mice were left 
unstimulated or stimulated with 30 or 100 ng/ml LPS or 30 or 100 
ng/ml STAg at 37°C for 24 h. IL-12 p40 (A and B) and TNFα (C and D) 
levels in culture supernatants were determined by ELISA. (E–J) Meas-
urement of cytokine production by BMMϕ. BMMϕ from WT and 
DGKζ−/− mice were left unstimulated or stimulated with 100 ng/ml 
LPS (E and F), 50 ng/ml Pam3CSK4 (G and H), or 50 μg/ml Poly(I:C) 
(I and J) for 24 h. IL-12 p40 (E, G, and I) and TNFα (F, H, and J) levels 
in supernatants were detected by ELISA. (K) Cell surface expression of 
CD11b, TLR4, and other molecules on WT and DGKζ−/− BMMϕ. WT and 
DGKζ−/− BMMϕ were stained with a control antibody (dotted green 
line) or a biotin-labeled anti-TLR4 antibody, followed by PE-conjugated 
streptavidin staining or fl  uorescently labeled anti-CD11b, F4/80, CD80, 
CD86, or FcγR antibodies (WT, blue shaded region; DGKζ−/−, red line). 
Data shown in A–J are the mean ± SD of each group and represent 
three experiments.784  DGKζ IN TLR RESPONSES AND TOXOPLASMOSIS | Liu et al.
(Fig. 3, A and B). Northern blot analysis revealed decreased 
expression of both IL-12 p40 and TNFα mRNA in DGKζ-
defi  cient spleens as compared with WT spleens after injection 
of LPS (Fig. 3 C) or STAg (Fig. 3 D), suggesting that reduced 
IL-12 p40 and TNFα production by DGKζ-defi  cient mice is 
likely caused by decreased transcription or mRNA stability. 
Consistent with decreased TNFα production, DGKζ-  defi  cient 
mice were less susceptible to LPS-induced shock than WT 
mice (Fig. 3 E).
Immunofl   uorescence staining revealed similar numbers 
and distribution of CD11c+ DCs (green) in WT and DGKζ-
defi  cient spleens before STAg or LPS injection (Fig. 3 F, I 
and II). WT and DGKζ-defi  cient CD11c+ DCs migrated 
toward T cell areas of the spleen after injection of STAg (Fig. 
3 F, III and IV) or LPS (Fig. 3 F, V and VI). However, fewer 
CD11c+ cells expressed IL-12 (yellow) in DGKζ-defi  cient 
spleens compared with WT spleens after STAg or LPS injection. 
These data further confi  rm the requirement of DGKζ for 
TLR-induced IL-12 p40 production and indicate that 
  defi  ciency of DGKζ selectively aff  ects cytokine production 
without inhibition of DC migration.
DGK𝗇 defi  ciency does not cause impairment of I𝗋B 
degradation or activation of p38 and Erk1/2 MAPKs
To understand how DGKζ is integrated into TLR signaling, 
we fi   rst examined whether DGKζ defi   ciency may aff  ect 
IκBα degradation, an event downstream of the MyD88-
  dependent pathway that is critical for NF-κB activation and 
TLR-induced cytokine production. No decrease of TLR4-
induced IκBα degradation was found in DGKζ-defi  cient Mϕ 
after LPS stimulation (Fig. 4 A), suggesting that proximal 
signaling events leading to IκBα degradation are not inhibited 
and, therefore, are not likely to account for the inhibition of 
TLR-induced IL-12 and TNFα production in the absence 
of DGKζ expression. The MAPK Erk1/2 have been re-
ported to negatively regulate IL-12 production induced by 
several TLR ligands (9, 46, 47). No obvious enhancement 
of Erk1/2 activation, as assessed by their phosphorylation, 
Figure 3.  Impaired TNF𝗂 and IL-12 production in DGK𝗇-defi  cient 
mice after TLR-stimulation. (A and B) Measurement of serum cytokine 
concentrations by ELISA. WT and DGKζ−/− mice were intraperitoneally 
injected with 10 μg LPS or 5 μg STAg. 6 h after injection, sera were col-
lected for measurement of IL-12 p40 and TNFα production by ELISA. 
Data shown are the mean ± SD for each group and are representative of 
three experiments. (C and D) Measurement of cytokine messengers by 
Northern blot. WT and DGKζ−/− mice were intraperitoneally injected with 
10 μg LPS or 5 μg STAg. 2, 3, and 5 h after injection, total splenic RNA 
was isolated, and IL-12 p40 and TNFα transcripts were measured by 
Northern blot analysis. Data shown are representative of three experi-
ments. (E) Increased resistance to LPS-induced shock in DGKζ−/− mice. 
Age- and sex-matched WT mice (n = 10) and DGKζ−/− mice (n = 6) 
were intraperitoneally injected with 20 mg D-galactosamine and 2 μg 
LPS per mouse, and their survival was observed at the indicated time 
points. Data shown are representative of two independent experiments. 
(F) Detection of IL-12 production by immunofl  uorescence. Spleens were 
removed from mice 6 h after injection of PBS, LPS, or STAg. Frozen sec-
tions of spleens were processed and stained with a goat anti–mouse 
IL-12 p40 antibody, followed by a double incubation with Alexa Fluor 
488–conjugated anti–mouse CD11c and Alexa Fluor 594–conjugated 
anti–goat antibodies. The cells were counterstained for nuclei using DAPI. 
Images were captured using an Axiovert microscope with AxioVision 
software (see Materials and methods). Green, red, and blue represent 
CD11c+ DCs, IL-12, and nuclei, respectively; yellow represents CD11c+IL-12+ 
after overlay. Bars, 50 μm.JEM VOL. 204, April 16, 2007  785
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was observed in DGKζ-defi  cient Mϕ after LPS stimulation 
(Fig. 4 B). In addition, LPS-induced activation of the p38 
MAPK, a positive regulator of TLR-induced cytokine pro-
duction, was not impaired in DGKζ-defi  cient Mϕ (Fig. 
4 C), suggesting that the impaired cytokine production 
caused by DGKζ defi  ciency is not caused by inhibition of 
this MAPK.
DGK𝗇 defi  ciency causes increased activation 
of the PI3K–Akt pathway
The PI3K–Akt pathway can negatively regulate TLR-
  induced responses (33–35). How the PI3K–Akt pathway is 
controlled during TLR-induced responses is not clear. We 
examined the intracellular concentration of PIP3, the prod-
uct of PI3K (48, 49), before and after LPS stimulation. In 
WT BMMϕ, PIP3 was virtually undetectable before stimu-
lation or 10 min after LPS stimulation but was detectable 
60 min after LPS stimulation. In contrast, in DGKζ-defi  -
cient BMMϕ, PIP3 was readily detectable both before 
stimulation and 10 min after LPS stimulation. Furthermore, 
a higher level of PIP3 was observed in DGKζ-defi  cient 
BMMϕ than in WT BMMϕ 60 min after LPS stimulation 
(Fig. 5 A). Consistent with their elevated PIP3 levels in 
response to LPS stimulation, DGKζ-defi  cient BMMϕ ex-
hibited higher levels of Akt phosphorylation, an event 
downstream of PI3K activation (Fig. 5 B). A similar eleva-
tion of Akt phosphorylation was observed in DGKζ-defici-
ent splenic DCs before and after LPS stimulation (unpublished 
data). These observations reveal that DGKζ is a novel 
negative regulator of the PI3K–Akt pathway in both Mϕ 
and DCs.
Figure 4.  Assessment of I𝗋B𝗂 degradation and Erk1/2 and p38 
activation in DGK𝗇-defi  cient M𝗟 after TLR4 stimulation. DGKζ+/+ 
and DGKζ−/− BMMϕ were rested in RPMI 1640 medium supplemented 
with 0.5% FBS for 3 h. Cells were left unstimulated (U) or stimulated with 
100 ng/ml LPS for the indicated times. Proteins in total cell lysates were 
separated by SDS-PAGE and levels of IκBα (A), phospho-Erk1/2 (B), and 
phospho-p38 (C) were determined by Western blot with anti-IκBα, anti–
phospho-Erk1/2, and anti–phospho-p38 antibodies. The blots were 
stripped and reprobed with anti-Erk1/2 and anti-p38 antibodies for 
 loading  control.
Figure 5.  Enhanced activation of the PI3K–Akt pathway in DGK𝗇-
defi  cient M𝗟 after TLR4 stimulation. (A) Elevated LPS-induced PIP3 
production in DGKζ-defi  cient BMMϕ. WT and DGKζ-defi  cient BMMϕ were 
rested in phosphate-free RPMI 1640 with 0.5% FBS at 37°C for 3 h, with 
the last 90 min supplemented with [32P]orthophosphate. Cells were left 
unstimulated or stimulated with 100 ng/ml LPS for 10 and 60 min. Total 
lipids were extracted and separated by TLC. PIP3 (molecular mass ≈ 1.2 kD) 
was visualized using a Phosphorimager (see Materials and methods). 
Data shown are representative of three experiments. (B) Enhanced 
Akt activation in DGKζ−/− Mϕ. WT (+/+) and DGKζ-defi  cient (−/−) 
BMMϕ were stimulated as in Fig. 4, but Western blots were probed using 
an anti–phospho-Akt (Ser473) antibody. The blot was stripped and rep-
robed with an anti-Akt antibody to determine equal protein loading. Data 
shown are representative of three experiments. (C) Restoration of LPS-
induced IL-12 production in DGKζ-defi  cient Mϕ by inhibition of PI3K or 
by exogenous PA. WT and DGKζ-defi  cient Mϕ were left unstimulated or 
stimulated with 100ng/ml LPS in the absence or presence of indicated 
concentrations of Ly294002 or PA at 37°C for 24 h. IL-12 p40 levels in 
supernatants were measured with ELISA. Data shown are representative 
of three experiments. Data shown are the mean ± SD.786  DGKζ IN TLR RESPONSES AND TOXOPLASMOSIS | Liu et al.
Restoration of LPS-induced IL-12 production by inhibition 
of PI3K and by PA
To test whether enhanced activation of the PI3K–Akt pathway 
contributes to impairment of TLR-induced cytokine responses 
in DGKζ-defi  cient Mϕ, WT and DGKζ-defi  cient Mϕ were 
treated with Ly294002, a PI3K inhibitor, during LPS stimula-
tion. As shown in Fig. 5 C, 10 nM Ly294002 promoted IL-12 
production by both WT and DGKζ-defi  cient Mϕ. Increasing 
Ly294002 concentrations further enhanced IL-12 production 
by DGKζ-defi  cient Mϕ. These observations, together with the 
biochemical studies shown in Fig. 5 (A and B), indicate that 
DGKζ positively contributes to TLR-induced proinfl  amma-
tory cytokine production by inhibiting the function of PI3K, 
a natural inhibitor of TLR-induced responses.
DGKζ defi  ciency is expected to increase DAG levels and de-
crease PA levels. To test whether DGK-derived PA may contrib-
ute to TLR-induced responses, WT and DGKζ-defi  cient Mϕ 
were stimulated with LPS in the absence or presence of diff  ering 
concentrations of PA (Fig. 5 C). PA promoted IL-12 production 
by WT and DGKζ-defi  cient Mϕ. When treated with 1 or 10μM 
PA, DGKζ-defi  cient Mϕ produced similar levels of IL-12 as WT 
Mϕ. This observation suggests that DGKζ-derived PA plays a 
positive role in supporting LPS-induced IL-12 production.
Impairment of Th1 immune responses against T. gondii 
in DGK𝗇-defi  cient mice
Host resistance to T. gondii requires TLR-induced IL-12 pro-
duction by APCs and subsequent induction of IFN-γ produc-
tion from NK cells and Th1-type CD4 T cells (22, 50, 51). As 
DGKζ defi  ciency causes decreased IL-12 p40 production after 
in vivo and in vitro STAg stimulation, we next examined 
whether DGKζ defi  ciency may aff  ect host defense against 
T. gondii. Both C57BL/6 WT and DGKζ-defi  cient mice were 
intraperitoneally challenged with live T. gondii bradyzoite cysts 
(strain ME49). Serum IL-12 p40 and IFN-γ levels in T. gondii–
infected DGKζ-defi  cient mice were much lower than in WT 
mice on days 5 and 7 after infection, respectively (Fig. 6, A and 
B), suggesting impairment of innate immune responses against 
T. gondii. On days 15 and 30 after infection, DGKζ-defi  cient 
and WT splenocytes were stimulated ex vivo with STAg for 
24 h. DGKζ-defi  cient splenocytes produced less IFN-γ than 
WT cells after stimulation, indicating that the Th1 immune 
response against T. gondii was inhibited in DGKζ-defi  cient 
mice (Fig. 6, C and D). Despite this fi  nding, there were similar 
total T cell numbers, as well as CD4 and CD8 T cell subsets, in 
DGKζ-defi  cient and WT spleens (Fig. 6 E). Interestingly, there 
were higher percentages of CD44+CD62Llow CD4 T cells in 
DGKζ-defi  cient spleens compared with WT spleens on days 
15 and 30 after infection (Fig. 6 F). Although there were simi-
lar or slightly lower percentages of CD44+CD62Llow CD8 
T cells in DGKζ-defi  cient spleens on day 15 after infection, 
on day 30 we observed a similar increase in the percentage of 
CD44+CD62Llow CD8 T cells in DGKζ-defi  cient spleens. 
These observations suggest that the decreased IFN-γ produc-
tion was not caused by a decrease in T cell numbers or an 
  inability to activate DGKζ-defi  cient T cells.
Figure 6.  Impaired innate and T cell responses to T. gondii infec-
tion in DGK𝗇-defi  cient mice. C57BL/6 WT and DGKζ−/− mice 
were intraperitoneally injected with 20 cysts of ME49 strain T. gondii. 
(A and B) Decreased serum IL-12 and IFN-γ concentrations in DGKζ-defi  cient 
mice. Serum IL-12 (A) was measured 5 d after infection, and IFN-γ (B) was 
measured 7 d after infection by ELISA. Data shown are representative 
of three experiments. Horizontal lines in A and B indicate the means. 
(C and D) Recall responses. At day 15 (C) and day 30 (D) after T. gondii 
infection, splenocytes from WT and DGKζ-defi  cient mice were left unstimu-
lated or stimulated with STAg at 37°C for 24 h. IFN-γ in the culture super-
natant was measured by ELISA. (E) Splenic CD4 and CD8 T cell numbers in 
WT and DGKζ-defi  cient mice after T. gondii infection. Splenic T cell subsets 
from uninfected and T. gondii–infected mice were determined after enu-
meration and FACS analysis. (F) CD44 and CD62L staining on splenic CD4 
and CD8 T cell subsets of CD4 and CD8 T cells as in E. Data shown are repre-
sentative of three experiments. Data shown in C–F are the mean ± SD.JEM VOL. 204, April 16, 2007  787
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DGK𝗇-defi  cient mice succumbed to toxoplasmosis
To further determine how DGKζ defi  ciency may aff  ect host 
resistance to T. gondii, we examined brain cyst numbers in 
WT and DGKζ-defi  cient mice after infection with this para-
site. Consistent with the impairment of innate and adaptive 
immune responses against T. gondii, the brain parasite cyst 
number in infected DGKζ-defi  cient mice was more than 
twofold higher than in WT mice on day 15 after infection 
(Fig. 7 A). The fold increase in brain cysts in DGKζ-defi  cient 
mice was even more dramatic at a late stage of infection (Fig. 
7 B). Immunofl  uorescence staining for T. gondii with an an-
tibody specifi  c for T. gondii cyclophilin-18 showed increased 
cyst numbers and cyst sizes in DGKζ-defi  cient brain tissues 
compared with WT brain (Fig. 7 C, I–IV), further confi  rm-
ing the inability of DGKζ-defi  cient mice to eff  ectively con-
trol this infection. Hematoxylin and eosin (H&E) staining of 
paraffi     n-embedded sections showed a striking increase in 
mononuclear cell infi  ltration in brains from DGKζ-defi  cient 
mice compared with WT mice on day 30 after infection 
(Fig. 7 D), indicating the persistence of active infl  ammation 
in DGKζ-defi  cient  brains.  DGKζ-defi   cient mice showed 
signs of disease, such as increased lethargy and rough fur, 
starting  20–30 d after infection. All DGKζ-defi  cient mice 
succumbed to toxoplasmosis between 45 to 55 d after infec-
tion (Fig. 7 E). In contrast, all WT mice remained healthy 
and survived the infection. Collectively, these observations 
indicate that DGKζ defi  ciency results in impaired innate im-
munity against T. gondii, which may cause defective induc-
tion of Th1 immune responses and ineff  ective control of this 
parasitic infection.
D  I  S  C  U  S  S  I  O  N 
In this report, we show that DGKζ defi  ciency causes impaired 
innate immune responses to T. gondii and decreased suscepti-
bility to endotoxin-induced shock, as well as decreased IL-12 
and TNFα production in response to LPS and several other 
TLR ligands. These alterations in immune cell function corre-
late with increased activation of the PI3K–Akt pathway in 
DGKζ-defi  cient Mϕ. Inhibition of PI3K in DGKζ-defi  cient 
Mϕ can restore IL-12 production. Thus, our data indicate that 
DGKζ positively contributes to TLR-induced responses by 
negatively regulating the PI3K–Akt pathway. The conclusion 
is consistent with the reported observations that class IA PI3Ks 
negatively control TLR-mediated responses (33–35). Of note, 
inhibition of the PI3K–Akt pathway by DGKζ is not limit  ed 
to Mϕ and DCs. In mast cells, DGKζ defi  ciency enhances 
Akt phosphorylation and cell survival in vitro in the presence 
or absence of surviving cytokines (41). Thus, DGKζ may have 
a broader role as a negative regulator of PI3K in diff  erent 
cell lineages.
At present, it is not known how DGKζ controls PI3K ac-
tivation, but it is possible that both DAG- and PA-mediated 
mechanisms could be involved (Fig. 8). On one hand, DGKζ 
could negatively control PI3K through its product, PA. The 
Src homology 2 domain–containing phosphatase 1 (SHP-1) is 
a PA eff  ector molecule that can bind to PA. Association with 
Figure 7.  Increased susceptibility to T. gondii infection in DGK𝗇-defi  cient 
mice. (A and B) Brain T. gondii cyst counts in WT and DGKζ−/− mice on day 15 (A) 
and day 45 (B) after infection. Brain homogenates (n = 3) were examined for the 
presence of T. gondii cysts at the indicated times after peritoneal injection of ME49 
strain parasites. Data shown are representative of three experiments. Data shown 
in A and B are the mean ± SD. (C) Detection of brain T. gondii cysts by immuno-
fl  uorescence. Frozen brain sections from T. gondii–infected WT and DGKζ-defi  cient 
mice were stained with an anti–cyclophilin-18 antibody (1499), followed by detec-
tion with Alexa Fluor 488–conjugated secondary chicken anti–rabbit IgG. Nuclei 
were detected by DAPI staining. Green and blue, T. gondii cysts and nuclei, respec-
tively. Bars: (I and II) 250 μm; (III and IV) 50 μm. (D) H&E staining of brain paraffi  n 
sections from WT and DGKζ-defi  cient mice 30 d after T. gondii infection. Bars, 
100 μm. (E) Enhanced susceptibility of DGKζ-defi  cient mice to toxoplasmosis. 
Six WT and DGKζ-defi  cient mice were intraperitoneally infected with T. gondii, 
and survival was monitored. Data shown are representative of three experiments.788  DGKζ IN TLR RESPONSES AND TOXOPLASMOSIS | Liu et al.
PA may increase the enzyme activity of SHP-1 (52). In 
T cells and osteoclasts, SHP-1 can dephosphorylate the p85α 
subunit to inhibit activation of the class IA PI3K (53, 54). 
DGKζ defi  ciency may decrease PA production and SHP-1 
activity, leading to alleviation of the negative control of 
PI3K by SHP-1. In support of this hypothesis, we have found 
that treatment of DGKζ-defi  cient Mϕ with exogenous PA 
restores TLR-induced IL-12 production, suggesting that 
DGKζ-derived PA promotes TLR-induced proinfl  ammatory 
responses. On the other hand, DGKζ defi  ciency could lead to 
accumulation of DAG and subsequent activation of Ras 
through Ras guanyl nucleotide-releasing protein (RasGRP) 
or protein kinase C (PKC), two important families of DAG 
eff  ector molecules (55–57). PKCα and β have been shown to 
be required for STAg-induced IL-12 production (58). Based 
on this fi  nding, it is unlikely that these PKC isoforms mediate 
signaling events that inhibit IL-12 production in DGKζ-defi  -
cient Mϕ and DCs. It has been previously shown that en-
hanced Ras activity can promote PI3K activation (59). In this 
regard, it is interesting to note that Ras can be activated by 
TLR2 (60). Therefore, it is possible that an increase of Ras-
GRP and Ras activity in DGKζ-defi  cient Mϕ and DCs could 
increase PI3K activity during TLR stimulation. Studies are 
ongoing to distinguish between these possibilities.
It is intriguing that DGKζ defi  ciency causes enhanced 
immune responses against lymphocytic choriomeningitis 
virus (LCMV) (40) but decreases host resistance to T. gondii. 
These seemingly opposite eff  ects could be caused by the dif-
ferential requirements of innate immunity and microbial 
re  cognition mechanisms for eff   ective clearance of these 
pathogens. For example, TLR-independent viral recognition 
mechanisms, such as the RNA helicase retinoid acid induc-
ible gene I–mediated pathway (61, 62), have been identifi  ed 
and contribute to host defense against viral infection. At pres-
ent, whether DGKζ is involved in TLR-independent viral 
recognition is not known. Furthermore, IL-12 appears to 
have diff  erent roles in host resistance to LCMV and T. gondii. 
Loss of IL-12 in mice dramatically reduces host resistance to 
T. gondii (51, 63). However, immune responses to LCMV 
infection and clearance of the virus are not impaired in 
IL-12–defi  cient mice (64). Our data showing that DGKζ is 
required for mice to survive T. gondii infection are consistent 
with the role of DGKζ for optimal IL-12 production in 
response to T. gondii and the requirement of IL-12 for host 
resistance against this parasite. The impairment of IL-12 pro-
duction in DGKζ-defi  cient mice may not substantially aff  ect 
host immune responses against LCMV infection. LCMV-
specifi  c CD8 T cells are massively expanded and activated in 
response to LCMV infection and are critical in host defense 
against LCMV (65). The enhanced immune responses against 
LCMV infection in DGKζ-defi  cient mice are likely caused 
by elevated expansion and activation of IFN-γ–producing 
CD8 T cells (40).
It is important to note that both WT and DGKζ-defi  -
cient CD4 and CD8 T cells manifest a similar kinetics of 
expansion and contraction during the course of T. gondii 
infection. Although DGKζ-defi  cient mice are susceptible to 
toxoplasmosis, T cell activation, as assessed by increased ex-
pression of CD44 and reduced expression of CD62L, appears 
enhanced in DGKζ-defi  cient mice compared with WT mice. 
Despite signs of activation, Th1 immune responses are dra-
matically inhibited in DGKζ-defi  cient T cells, as seen by 
their reduced production of IFN-γ in response to ex vivo 
stimulation with STAg. These observations suggest that the 
impairment of TLR-induced IL-12 production may selec-
tively inhibit Th1 immune responses but not globally inhibit 
T cell activation. The increase of T cell activation during 
T. gondii infection could be caused by the intrinsic hyperre-
sponsiveness of DGKζ-defi  cient T cells or the persistence of 
T. gondii infection in DGKζ-defi  cient mice.
DGKζ-defi  cient mice succumbed to toxoplasmosis with 
a delayed kinetics when compared with MyD88- or IL-12–
defi  cient mice (22, 63). This observation is consistent with 
our data showing that DGKζ defi  ciency causes a substantial 
decrease, but not complete abolishment of, TLR-induced 
IL-12 production. Partial inhibition of TLR-induced cyto-
kine production could be caused by the expression of other 
DGK isoforms in DCs and Mϕ (unpublished data), which 
may compensate for the loss of DGKζ expression. Addition-
ally, PA and DAG can be produced by other enzymes such as 
phosphatidylcholine-specifi  c phospholipase C and D, which 
may also contribute to TLR-induced cytokine production 
(15–17). However, even if these enzymes participate in 
TLR-induced innate immune responses, they are not able to 
completely compensate for DGKζ defi  ciency.
Although DGKζ defi  ciency causes enhanced activation 
of the PI3K–Akt pathway, it does not globally inhibit TLR 
signaling. For example, TLR-induced IκBα degradation and 
activation of Erk1/2 and p38 MAPKs are not altered in 
DGKζ-defi  cient Mϕ. The selective role of DGKζ on spe-
cifi  c signaling events may diff  erentially aff  ect TLR-induced 
responses. As we have shown in Fig. 3, loss of DGKζ expres-
sion inhibits TLR-induced IL-12 p40 and TNFα production 
Figure 8.  Potential mechanisms of DGK𝗇 function in TLR-induced 
proinfl  ammatory responses. DGKζ activity could negatively control PI3K 
through its product, PA. PA may associate with and increase SHP-1 activ-
ity. SHP-1 may dephosphorylate PI3K and inhibit its activation to promote 
TLR-induced proinfl  ammatory cytokine production. Alternatively, DGKζ 
could inactivate DAG and subsequently inhibit Ras activation through 
RasGRPs, leading to a decrease of PI3K activity.JEM VOL. 204, April 16, 2007  789
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but not DC migration. These diff  erential eff  ects of DGKζ on 
TLR responses are consistent with the proposed roles of 
PI3K during TLR-induced cytokine production and DC 
migration. Specifi  cally, PI3K is believed to positively regu-
late DC migration but inhibit IL-12 production after TLR 
engagement (44, 46, 47). Therefore, in the absence of 
DGKζ, enhanced PI3K signals would be expected to sup-
port DC migration but negatively infl  uence proinfl  amma-
tory cytokine production.
It is interesting to note that DGKζ performs a variety of 
roles in response to diff  erent receptors within the immune 
system. In T cells, DGKζ functions as a negative regulator of 
T cell receptor signaling and T cell activation by inhibiting 
DAG-mediated activation of the Ras–Erk1/2 pathway (39, 
40, 66). In mast cells, DGKζ performs both positive and neg-
ative roles in FcεRI-induced responses. It positively contrib-
utes to FcεRI-induced mast cell degranulation by promoting 
Ca2+ infl   ux but negatively controls FcεRI-induced IL-6 
production and survival via inhibition of Ras, Erk, and Akt 
(41). In DCs and Mϕ, DGKζ positively contributes to TLR-
induced cytokine responses, which correlates with inhibition 
of PI3K activity. The diff  erential eff  ects of DGKζ defi  ciency 
on FcεRI-induced IL-6 production in mast cells and on 
LPS-induced IL-12 production in DCs and Mϕ may refl  ect 
diff  erences in transcriptional activation between these two 
genes. Such diff  erential eff  ects could also be caused by the 
distinct roles of signaling pathways downstream of diff  erent 
receptors in activating transcription of these two cytokines. 
Collectively, these observations reveal the importance of 
DGKζ in these lineages and suggest that by diff  erential mod-
ulation of DAG and/or PA-mediated signaling pathways, 
DGKζ regulates diverse cellular processes.
In summary, the current study provides the fi  rst genetic 
evidence that an enzyme involved in DAG and PA metabo-
lism is important for TLR-induced innate immune responses 
in vitro and in vivo and for host defense against T. gondii. 
DGKζ negatively regulates the PI3K–Akt pathway in response 
to TLR4 stimulation. We propose that DGKζ may function 
as a positive regulator of TLR-induced proinfl  ammatory 
  responses by facilitating PA-dependent signaling events.
MATERIALS AND METHODS
Mice. Previously described DGKζ-defi  cient mice (40) were backcrossed to 
the C57BL/6 background for more than seven generations. Mice used for 
experiments were between 6–12 wk old. All animal experiments were per-
formed according to protocols approved by the Institutional Animal Care 
and Use Committee at Duke University.
Isolation of splenic DCs. Spleens from WT and DGKζ−/− mice were di-
gested with 1 mg/ml collagenase D (0.5ml/spleen; Roche Diagnostics) in a 
digestion buff  er (10 mM Hepes-NaOH [pH 7.4], 150 mM NaCl, 5 mM 
KCl, 1 mM MgCl2, 1.8 mM CaCl2) for 30 min at 37°C. The spleens were 
then smashed into a single-cell suspension, and the low-density leukocytes 
were obtained by centrifuging the cell suspension on a dense BSA gradient, 
as previously described (67). DCs were further purifi  ed from splenic low-
density leukocytes by MACS using anti-CD11c microbeads according to the 
manufacturer’s protocol (Miltenyi Biotec). The purifi  ed DCs were routinely 
70–85% CD11c+, as determined by FACS analysis.
Generation of BMM𝗟. Bone marrow cells from femurs and tibias were 
plated into Petri dishes containing RPMI 10 (RPMI 1640 medium supple-
mented with 10% FBS, 100 U/ml penicillin, 1,000 U/ml streptomycin, and 
20 mM l-glutamine) and 20% L929 cell- conditioned medium. After 2–3 d 
of culture at 37°C in CO2 incubator, nonadherent cells were colleted and 
cultured in fresh medium for another 3–5 d before being used for experi-
ments. More than 95% of cells were CD11b+ using fl  ow cytometry analysis.
In vitro stimulation for cytokine production. Splenic DCs and BMMϕ 
were cultured in 96-well plates at a concentration of 2 × 105 cells/well and 105 
cells/well, respectively, in 200 μl RPMI 10. Cells were left unstimulated or 
stimulated with 30 or 100 ng/ml STAg, 100 ng/ml LPS, 50 ng/ml Pam3CSK4, 
or 50 μg/ml Poly(I:C) for 24 h. STAg was prepared from sonicated T. gondii 
(RH strain) tachyzoites, as previously described (68). Synthetic bacterial lipo-
peptide Pam3CSK4 and Poly(I:C) were purchased from Apotech. LPS from 
E. coli serotype 0111:B4 was obtained from both Apotech and Sigma-Aldrich. 
IL-12 p40 and TNFα levels in the culture supernatants were measured by 
ELISA (R&D Systems).
In vivo LPS and STAg stimulation. DGKζ-defi  cient and C57BL/6 
mice were intraperitoneally injected with 10 μg LPS or 5 μg STAg. To 
measure TNFα and IL-12 p40, sera were collected 6 h after injection, and 
cytokine concentrations were determined by ELISA. For analysis of TNFα 
and IL-12 p40 mRNA levels, total splenic RNA was isolated before and af-
ter LPS or STAg injection using the TRIzol reagent, according to the man-
ufacturer’s protocol (Invitrogen). 10 μg of total RNA from each sample was 
resolved in a formaldehyde-containing agarose gel, transferred to a nylon 
membrane, and hybridized with 32P-labeled probes for IL-12 p40 and 
TNFα. The blots were stripped and probed with a 32P-labeled GAPDH 
probe for loading control.
Endotoxic shock. 6-wk-old sex-matched C57BL/6 and DGKζ-defi  cient 
mice were intraperitoneally injected with 20 mg d-galactosamine (Sigma-
Aldrich) and 2 μg LPS (Sigma-Aldrich) in 0.2 ml PBS per mouse. Survival 
of mice was monitored over time at 30-min intervals.
Measurement of intracellular PIP3 levels. PIP3 level was measured as 
previously described, with modifi  cations (48). In brief, BMMϕ were plated 
in 60-mm dishes at the density of two million cells per dish. After overnight 
incubation at 37°C, culture medium was replaced with 2 ml of phosphate-
free medium with 0.5% FBS and cultured for another 3 h, with the last 
90 min supplemented with 100 μCi [32P]orthophosphate. Cells were left un-
stimulated or stimulated with 100 ng/ml of LPS for 10 and 60 min. Total lip-
ids were extracted with methanol/chloroform (2:1, vol/vol), dried, redissolved 
in chloroform/methanol (1:1), and separated by TLC using a solvent (chlo-
roform/acetone/methanol/acetic acid/water [80:30:26:24:14]). PIP3 was 
identifi  ed by the use of a co-migrating standard with iodine vapor staining 
and revealed by a Phosphorimager (Typhoon 9410; Amersham Biosciences).
Measurement of p38 and Erk1/2 MAPK activation, Akt phosphory-
lation, and I𝗋B degradation. WT and DGKζ-defi  cient BMMϕ were 
plated on 6-cm dishes at a concentration of 2 × 106 cells/dish and incu-
bated at 37°C overnight. Cells were rested in 0.5% FBS-RPMI at 37°C for 
3 h and were left unstimulated or stimulated with 100 ng/ml LPS for the 
times indicated in the fi  gures. Akt, Erk1/2, and p38 phosphorylation and 
IκBα protein levels were determined by Western blot using anti–phospho-Akt 
(Ser473), anti–phospho-Erk1/2, anti–phospho-p38, and anti-IκBα anti-
bodies, respectively (Cell Signaling Technology). The blots were probed 
with anti-Akt, anti-Erk1/2, and anti-p38 antibodies for loading control (Cell 
Signaling Technology).
T. gondii infection. T. gondii infection was performed as previously de-
scribed (51). In brief, WT and DGKζ-defi  cient mice were intraperitoneally 
injected with 20 or 40 cysts of ME49 strain T. gondii. On days 5 and 7 after 
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production, respectively, by ELISA. During the course of infection, T. gondii 
cysts in brain homogenates were counted by light microscopy. Survival of 
mice was monitored over time.
To measure T cell recall responses, spleens were harvested from mice 
that had been infected with T. gondii 15 or 30 d earlier. Total splenocytes 
were enumerated and analyzed by FACScan after staining with antibodies 
for CD4, CD8, CD3, CD44, and CD62L. Splenocytes were also seeded in 
U-bottom 96-well plates at a concentration of 5 × 105 cells/well in 200 μl 
RPMI 10 with or without 100 ng/ml STAg. After 24 h incubation at 
37°C, IFN-γ concentrations in the culture supernatants were determined 
by ELISA.
Microscopy. Spleens were removed from mice before or 6 h after STAg or 
LPS stimulation, and frozen sections were processed and stained with a goat 
anti–mouse IL-12 p40 (BD Biosciences), followed by a double incubation 
with Alexa Fluor 488–conjugated anti–mouse CD11c and Alexa Fluor 594–
conjugated anti–goat antibodies (Invitrogen). The cells were counterstained 
for nuclei with DAPI (Invitrogen). Images were captured using a micro-
scope (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) with the AxioVision 
software (Carl Zeiss MicroImaging, Inc.).
To visualize T. gondii cysts by immunofl  uorescence microscopy, frozen 
brain sections from T. gondii–infected WT and DGKζ-defi  cient mice were 
stained with an anti–cyclophilin-18 antibody (1499) (24), followed by detec-
tion with Alexa Fluor 488–conjugated secondary chicken anti–rabbit IgG 
(Invitrogen). Nuclei were stained with DAPI, and images were captured as 
described in the previous paragraph.
H&E staining. 30 d after T. gondii infection, WT and DGKζ−/− mice were 
sequentially perfused with 10 ml PBS and 20 ml 4% paraformaldehyde. The 
brains were then harvested and fi  xed with 10% formalin overnight. After 
dehydration with increased concentrations of ethanol and embedment in 
paraffi   n, thin sections were cut and stained with H&E according to standard 
procedures (70).
Statistical analysis. Experimental data are expressed as the mean ± SD. The 
statistical signifi  cance of diff  erences in mean values of cytokine concentrations 
and cyst numbers was determined using the Student’s t test. Survival data are 
presented as a Kaplan Meier survival curve and analyzed using the log-rank test. 
Diff  erences having a p-value <0.05 are considered signifi  cant.
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